Amylyx Pharmaceuticals, Inc. (AMLX): 8-K filed Sep 8, 2026

Form type

8-K

Filing date

Sep 8, 2026

Accession number

0001193125-26-385331

Filer

Amylyx Pharmaceuticals, Inc. (CIK 1658551)